Status:

UNKNOWN

Validation of the Utility of Strabismus Intelligent Diagnostic System

Lead Sponsor:

Sun Yat-sen University

Conditions:

Ophthalmological Disorder

Strabismus

Eligibility:

All Genders

Brief Summary

Strabismus affects approximately 0.8%-6.8% of the world's population and appears by the age of 3 years in 65% of affected individuals. Manual measurement of deviation is often laborious and highly dep...

Eligibility Criteria

Inclusion

  • Patients in the outpatient clinic of strabismus department.

Exclusion

  • Patients or their parents diagree to participate in the trial.
  • Patients with blepharoptosis.
  • Patients can't facing forward or lacking fixation.

Key Trial Info

Start Date :

September 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 10 2020

Estimated Enrollment :

323 Patients enrolled

Trial Details

Trial ID

NCT04416776

Start Date

September 1 2019

End Date

June 10 2020

Last Update

June 4 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, China, 510080

Validation of the Utility of Strabismus Intelligent Diagnostic System | DecenTrialz